PL361399A1 - Sposób otrzymywania 4-(17alfa-podstawionych-3-oksoestra-4,9-dien-11beta-ylo)benzaldehydo-(1E lub 1Z)-oksymów - Google Patents

Sposób otrzymywania 4-(17alfa-podstawionych-3-oksoestra-4,9-dien-11beta-ylo)benzaldehydo-(1E lub 1Z)-oksymów

Info

Publication number
PL361399A1
PL361399A1 PL01361399A PL36139901A PL361399A1 PL 361399 A1 PL361399 A1 PL 361399A1 PL 01361399 A PL01361399 A PL 01361399A PL 36139901 A PL36139901 A PL 36139901A PL 361399 A1 PL361399 A1 PL 361399A1
Authority
PL
Poland
Prior art keywords
sub
oxoestra
benzaldehyd
11beta
17alpha
Prior art date
Application number
PL01361399A
Other languages
English (en)
Other versions
PL205091B1 (pl
Inventor
Gerd Schubert
Sven Ring
Bernd Erhart
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of PL361399A1 publication Critical patent/PL361399A1/pl
Publication of PL205091B1 publication Critical patent/PL205091B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0085—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Studio Devices (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
PL361399A 2000-11-10 2001-11-09 Sposób otrzymywania 4-(17α-podstawionych-3-oksoestra-4,9-dien-11β-ylo)benzaldehydo-(1E lub 1Z)-oksymów PL205091B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10056676A DE10056676A1 (de) 2000-11-10 2000-11-10 Verfahren zur Herstellung von 4-/17alpha-substituierten-3-oxoestra-4,9-dien-11beta-yl)benzaldehyd-(1E oder 1Z)-oximen
PCT/DE2001/004218 WO2002038582A2 (de) 2000-11-10 2001-11-09 Verfahren zur herstellung von 4-(17alpha-(substituierten-methyl)-3-oxoestra-4,9 dien-11-yl)benzaldehyd-(1e oder 1z)-oximen

Publications (2)

Publication Number Publication Date
PL361399A1 true PL361399A1 (pl) 2004-10-04
PL205091B1 PL205091B1 (pl) 2010-03-31

Family

ID=7663441

Family Applications (1)

Application Number Title Priority Date Filing Date
PL361399A PL205091B1 (pl) 2000-11-10 2001-11-09 Sposób otrzymywania 4-(17α-podstawionych-3-oksoestra-4,9-dien-11β-ylo)benzaldehydo-(1E lub 1Z)-oksymów

Country Status (25)

Country Link
US (1) US7214808B2 (pl)
EP (1) EP1339734B1 (pl)
JP (1) JP4263478B2 (pl)
KR (1) KR100836323B1 (pl)
CN (1) CN100368427C (pl)
AT (1) ATE337328T1 (pl)
AU (2) AU1691102A (pl)
BG (1) BG107886A (pl)
BR (1) BR0115249A (pl)
CA (1) CA2427632C (pl)
CZ (1) CZ301425B6 (pl)
DE (2) DE10056676A1 (pl)
EA (1) EA005530B1 (pl)
EE (1) EE200300222A (pl)
HR (1) HRP20030458A2 (pl)
HU (1) HUP0301765A2 (pl)
IL (2) IL155680A0 (pl)
MX (1) MXPA03004109A (pl)
NO (1) NO20032080L (pl)
NZ (1) NZ525962A (pl)
PL (1) PL205091B1 (pl)
SK (1) SK286601B6 (pl)
WO (1) WO2002038582A2 (pl)
YU (1) YU34303A (pl)
ZA (1) ZA200304480B (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006018888A1 (de) * 2006-04-18 2007-10-25 Bayer Schering Pharma Ag Verfahren zur Herstellung von 4-[17beta-Methoxy-17alpha-methoxymethyl-3-oxoestra-4,9-dien-11beta-yl]benzaldehyd-(E)-oxims (Asoprisnil)
JP4843372B2 (ja) * 2006-05-09 2011-12-21 株式会社リコー 画像処理装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4332283A1 (de) * 1993-09-20 1995-04-13 Jenapharm Gmbh Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4332284C2 (de) * 1993-09-20 1997-05-28 Jenapharm Gmbh 11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US5576310A (en) * 1994-09-20 1996-11-19 Jenapharm Gmbh 11-benzaldoxime-17β-methoxy-17α-methoxymethyl-estrasdiene derivatives, methods for their production and pharmaceuticals containing such compounds

Also Published As

Publication number Publication date
SK286601B6 (sk) 2009-02-05
CN100368427C (zh) 2008-02-13
US20040053905A1 (en) 2004-03-18
AU1691102A (en) 2002-05-21
AU2002216911C1 (en) 2002-05-21
WO2002038582A2 (de) 2002-05-16
EA200300506A1 (ru) 2003-12-25
JP4263478B2 (ja) 2009-05-13
IL155680A (en) 2009-06-15
KR20030081330A (ko) 2003-10-17
NZ525962A (en) 2005-02-25
EP1339734B1 (de) 2006-08-23
EA005530B1 (ru) 2005-04-28
CZ301425B6 (cs) 2010-02-24
ZA200304480B (en) 2004-08-24
MXPA03004109A (es) 2004-07-08
ATE337328T1 (de) 2006-09-15
CN1474829A (zh) 2004-02-11
YU34303A (sh) 2006-08-17
US7214808B2 (en) 2007-05-08
DE50110829D1 (de) 2006-10-05
IL155680A0 (en) 2003-11-23
EP1339734A2 (de) 2003-09-03
PL205091B1 (pl) 2010-03-31
DE10056676A1 (de) 2002-05-16
CA2427632A1 (en) 2003-05-01
KR100836323B1 (ko) 2008-06-09
WO2002038582A3 (de) 2002-09-12
NO20032080D0 (no) 2003-05-09
BG107886A (bg) 2004-02-27
JP2004513179A (ja) 2004-04-30
CA2427632C (en) 2010-01-26
SK5512003A3 (en) 2003-10-07
HK1063187A1 (en) 2004-12-17
HRP20030458A2 (en) 2005-04-30
HUP0301765A2 (hu) 2003-09-29
BR0115249A (pt) 2003-08-12
NO20032080L (no) 2003-05-09
CZ20031282A3 (cs) 2003-08-13
EE200300222A (et) 2003-08-15
AU2002216911B2 (en) 2007-06-14

Similar Documents

Publication Publication Date Title
AU2001226100A1 (en) Method for high yield reticle formation
WO2002020501A3 (en) Polyarylcarboxamides useful as lipid lowering agents
PL300064A1 (en) Method of obtaining 7-(substituted)-9[(substituted glycil)amido]-6-demethyl-6-deoxy-tetracyclines
FI971489A0 (fi) Uusia bentsoksatsoleja
PL366590A1 (pl) Nowe związki jako środki przeciwzapalne, immunomodulujące i przeciwproliferacyjne
GR1004074B (el) Μεθοδος παρασκευης της σιταλοπραμης.
PT1101755E (pt) Derivados do acido antranilico
ATE332304T1 (de) Cefdinir salze als zwischenprodukte
NO20040388L (no) Fremgangsmåte for fremstilling av beraprost og salter derav, samt forbindelser som er mellomprodukter i fremgangsmåten
EA200200101A1 (ru) Получение замещенных пиперидин-4-онов
AU1691102A (en) Method for the production of 4-(17alpha substituted 3-oxoestra-4,9-dien-11beta-yl)benzaldehyd-(1e or 1z)-oximes
PT1347984E (pt) Processo para a preparacao de derivados de taxano
WO2002024690A3 (en) Efficient process for the preparation of a factor xa inhibitor
AU2001293856A1 (en) A process for the preparation of pantoprazole and intermediates therefor
PT1105392E (pt) Processo para a preparacao de intermediarios de imidazodiazepina
WO2002038581A3 (de) Verfahren zur herstellung von 4-(17alpha-substituierten-methyl) 3-oxoestra-4,9-dien-11beta-yl)benzaldehyd-(1e oder 1z)-oximen
EE200300090A (et) Asendatud imidasopüridiinühendite valmistamise meetod
DK0779895T3 (da) Forbedret fremgangsmåde til fremstilling af sidekædederivater af cyclohexapeptidyl-lipopeptider
PT1581504E (pt) Processo de preparação de derivados de imidazole substituídos e intermediários utilizados no processo
DK1219625T3 (da) Hidtil ukendte substituerede 2-(6-benzyl-5-oxo-3-phenyl-(S3,7S,7AR)-perhydroimidazol-(1,5-C)(1,3) thiazol-7YL)forbindelser
WO2000018777A3 (en) Method for synthesizing c-glycosides of ulosonic acids
BR0117363B1 (pt) processo para a preparação de um composto 2-cianopiridina de fórmula geral (ii)
AU2003250932A1 (en) Method for producing macrocyclic ketones by means of dieckmann condensation in the gas phase
AU2002216911A1 (en) Method for the production of 4-(17alpha substituted 3-oxoestra-4,9-dien-11beta-yl)benzaldehyd-(1E or 1Z)-oximes
EP1254893A3 (en) 2-halo-1-cycloalkenecarboxamides and their preparation

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20101109